Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L9ZQ
|
||||
Former ID |
DIB020291
|
||||
Drug Name |
lysergic acid
|
||||
Synonyms |
D-lysergic acid; isolysergic acid; (+)-lysergic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [538865] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H16N2O2
|
||||
InChI |
InChI=1S/C16H16N2O2/c1-18-8-10(16(19)20)5-12-11-3-2-4-13-15(11)9(7-17-13)6-14(12)18/h2-5,7,10,14,17H,6,8H2,1H3,(H,19,20)/t10-,14-/m1/s1
|
||||
InChIKey |
ZAGRKAFMISFKIO-QMTHXVAHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 5A receptor | Target Info | Agonist | [534080] | |
5-hydroxytryptamine 1D receptor | Target Info | Agonist | [534292] | ||
References | |||||
Ref 534080 | Expression of functional mouse 5-HT5A serotonin receptor in the methylotrophic yeast Pichia pastoris: pharmacological characterization and localization. FEBS Lett. 1995 Dec 27;377(3):451-6. | ||||
Ref 534292 | Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Mol Pharmacol. 1996 Dec;50(6):1567-80. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.